AGH 5.95 0.00 Vol 0 BAS 1.79 0.00 Vol 0 BFM 23 0.00 Vol 0 BG23B 0 0.00 Vol 0 BPH 4.25 0.00 Vol 0 DEVON 3.25 0.00 Vol 0 LOM 5.75 0.00 Vol 0 NTB 39 0.00 Vol 0 POLAR 0 0.00 Vol 0 SOM 18.01 0.00 Vol 0 WHHL 4.2 0.00 Vol 0 WWW 33 0.00 Vol 0
Market Closed:     
70 Sir John Rogerson’s Quay, Grand Canal Dock, Dublin 2, Ireland
Listed Since: 2020/03/20
Currency: USD
Telephone: 353 1 772 2100.

Horizon Therapeutics Ireland DAC, a designated activity company, incorporated under the laws of Ireland, registered with the Irish Companies Registration office under company number 376554 and with its parent company registered office at Connaught House, 1st Floor, 1 Burlington Road, Dublin 4, Ireland.The Issuer is an indirect wholly-owned subsidiary of the Parent. The Issuer provides treasury services to other companies within the Horizon group. The Noteholder is an indirect subsidiary of the Parent. The Noteholder HZNP Finance Limitedprovides financing services to other companies within the Horizon group. The Noteholder’s registered office is located at H.P. House, 21 Laffan Street, Hamilton HM 09, Bermuda.


Horizon Therapeutics Ireland DAC., US$4,174,571,989 – 6.9% Promissory Note due December 31, 2029;




08:30-09:00 Price Discovery 30 Victoria Street
09:00-16:30 Continuous Trading 3rd Floor
  Hamilton, Bermuda
TEL: +1 (441) 292 7212 P.O. Box HM 1369
FAX: +1 (441) 292 7619 Hamilton HMFX
The information contained in these pages has been obtained from sources which The Bermuda Stock Exchange believes are reliable. However, the accuracy of the information cannot and is not guaranteed and The Bermuda Stock Exchange makes no representation as to its accuracy or completeness. Neither this Web site, nor any information contained herein, constitutes advice or a solicitation to subscribe, purchase or sell any securities. The Bermuda Stock Exchange expressly disclaims any liability whatsoever for any loss howsoever arising from or in reliance upon any part of the contents of this site or any external sites referenced from this website.